[{"orgOrder":0,"company":"Ergomed","sponsor":"HAL Allergy","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"NETHERLANDS","productType":"Undisclosed","year":"2013","type":"Inapplicable","leadProduct":"Purethal Birch","moa":"Allergen cell","graph1":"Immunology","graph2":"Phase IV","graph3":"Ergomed","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ergomed \/ Ergomed","highestDevelopmentStatusID":"11","companyTruncated":"Ergomed \/ Ergomed"},{"orgOrder":0,"company":"Ergomed","sponsor":"Modus Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Genetic Disease","country":"SWEDEN","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Sevuparin","moa":"heparin derivatives and low molecular weight (or depolymerized) heparins","graph1":"Genetic Disease","graph2":"Phase II","graph3":"Ergomed","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Genetic Disease","amount2New":0,"dosageForm":"Infusion","sponsorNew":"Ergomed \/ Ergomed","highestDevelopmentStatusID":"8","companyTruncated":"Ergomed \/ Ergomed"},{"orgOrder":0,"company":"Ergomed","sponsor":"Gesynta Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Immunology","country":"SWEDEN","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"GS-248","moa":"mPGES-1","graph1":"Immunology","graph2":"Phase II","graph3":"Ergomed","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Ergomed \/ Ergomed","highestDevelopmentStatusID":"8","companyTruncated":"Ergomed \/ Ergomed"},{"orgOrder":0,"company":"Ergomed","sponsor":"Asarina Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Obstetrics\/Gynecology (Women\u2019s Health)","country":"SWEDEN","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"Allopregnanolone","moa":"steroids (not prednisolone derivatives)","graph1":"Obstetrics\/Gynecology (Women\u2019s Health)","graph2":"Phase II","graph3":"Ergomed","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Gynecology\/Obstetrics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Ergomed \/ Ergomed","highestDevelopmentStatusID":"8","companyTruncated":"Ergomed \/ Ergomed"}]